Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-SLC39A6 Antibody (8F657) is an antibody targeting SLC39A6. Anti-SLC39A6 Antibody (8F657) can be used in ELISA.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $209 | 7-10 days | |
100 μL | $349 | 7-10 days |
Description | Anti-SLC39A6 Antibody (8F657) is an antibody targeting SLC39A6. Anti-SLC39A6 Antibody (8F657) can be used in ELISA. |
Synonyms | ZIP6, LIV-1, LIV1 |
Ig Type | Human IgG1 |
Clone | 8F657 |
Reactivity | Human |
Verified Activity | 1. The Binding Activity of SLC39A6 with anti-SLC39A6 antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Human SLC39A6 at 1 μg/ml can bind Anti-SLC39A6-1 recombinant antibody, the EC50 is 0.6873-0.9010 ng/mL. 2. The Binding Activity of Cynomolgus SLC39A6 with Anti-SLC39A6 Recombinant Antibody Activity: Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus SLC39A6 at 2 μg/mL can bind Anti-SLC39A6 recombinant antibody. The EC50 is 0.8290-0.9864 ng/mL. |
Application | |
Antibody Type | Monoclonal |
Subcellular Localization | Cell membrane; Multi-pass membrane protein. |
Tissue Specificity | Highly expressed in the breast, prostate, placenta, kidney, pituitary and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. |
Construction | Recombinant Antibody |
Purification | Affinity-chromatography |
Appearance | Liquid |
Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
Research Background | May act as a zinc-influx transporter. |
Conjucates | Unconjugated |
Immunogen | Recombinant Protein: Human SLC39A6 Protein |
Antigen Species | Human |
Gene Name | SLC39A6 |
Gene ID | |
Uniprot ID | |
Biology Area | Immunology |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.